{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T05:07:43Z","timestamp":1780636063850,"version":"3.54.1"},"reference-count":56,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T00:00:00Z","timestamp":1780617600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The association between bipolar disorder (BD) and Parkinson's disease (PD) has been examined in several cohort studies, but existing evidence is limited by potential confounding and outcome misclassification. This meta-analysis aims to systematically evaluate this association while appraising the certainty of the evidence.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A comprehensive literature search was conducted in PubMed, Web of Science, Embase and the Cochrane Library from database inception to April 2026. Cohort studies reporting PD risk in individuals with BD were eligible for inclusion. The outcome was the incidence of PD, with hazard ratios (HRs) and 95% confidence intervals (95% CIs) as effect measures. Random-effects models were employed and 95% prediction intervals (95% PIs) were calculated to reflect the expected range of true effects across studies. Effect estimates were extracted as reported, with varying degrees of adjustment across studies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Six cohort studies fulfilled the predefined inclusion criteria. Pooled analysis demonstrated extreme heterogeneity (\n                      <jats:italic>I<\/jats:italic>\n                      <jats:sup>2<\/jats:sup>\n                      = 92.7%,\n                      <jats:italic>P<\/jats:italic>\n                      &amp;lt; 0.001), with an HR of 3.65 (95%\n                      <jats:italic>CI<\/jats:italic>\n                      2.16\u20136.17,\n                      <jats:italic>P<\/jats:italic>\n                      &amp;lt; 0.001, 95%\n                      <jats:italic>PI<\/jats:italic>\n                      , 0.67\u201320.00). Subgroup analyses were exploratory. Any observed differences by geographic region likely reflect variation in healthcare systems rather than biological effects. These findings are drawn from a limited number of observational studies with high risk of confounding and should be interpreted with caution.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This meta-analysis suggests an association between BD and subsequent PD diagnosis, with very low certainty of evidence. The pooled estimate should not be interpreted as representing a single underlying effect, and a causal interpretation is not warranted due to uncontrolled medication exposure, outcome misclassification, and extreme heterogeneity.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fneur.2026.1825046","type":"journal-article","created":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T04:59:08Z","timestamp":1780635548000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Bipolar disorder and subsequent Parkinson's disease: a meta-analysis of cohort studies"],"prefix":"10.3389","volume":"17","author":[{"given":"Lijing","family":"Su","sequence":"first","affiliation":[{"name":"Department of Neurology, Ningbo Hospital of Integrated Traditional Chinese and Western Medicine, Ningbo","place":["Zhejiang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoling","family":"Feng","sequence":"additional","affiliation":[{"name":"The Fifth School of Clinical Medical, Zhejiang Chinese Medical University, Hangzhou","place":["Zhejiang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yixia","family":"Chen","sequence":"additional","affiliation":[{"name":"The Fifth School of Clinical Medical, Zhejiang Chinese Medical University, Hangzhou","place":["Zhejiang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeqi","family":"Tang","sequence":"additional","affiliation":[{"name":"The Fifth School of Clinical Medical, Zhejiang Chinese Medical University, Hangzhou","place":["Zhejiang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Shi","sequence":"additional","affiliation":[{"name":"The Fifth School of Clinical Medical, Zhejiang Chinese Medical University, Hangzhou","place":["Zhejiang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yixian","family":"Qiu","sequence":"additional","affiliation":[{"name":"Emergency Medical Center, Ningbo Hospital of Integrated Traditional Chinese and Western Medicine, Ningbo","place":["Zhejiang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiongtao","family":"Ma","sequence":"additional","affiliation":[{"name":"Emergency Medical Center, Ningbo Hospital of Integrated Traditional Chinese and Western Medicine, Ningbo","place":["Zhejiang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,6,5]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/S1474-4422(21)00030-2","article-title":"Challenges in the diagnosis of Parkinson's disease","volume":"20","author":"Tolosa","year":"2021","journal-title":"Lancet Neurol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"e080952","DOI":"10.1136\/bmj-2024-080952","article-title":"Projections for prevalence of Parkinson's disease and its driving factors in 195 countries and territories to 2050: modelling study of Global Burden of Disease Study 2021","volume":"388","author":"Su","year":"2025","journal-title":"BMJ"},{"key":"B3","doi-asserted-by":"publisher","first-page":"956440","DOI":"10.3389\/fneur.2022.956440","article-title":"Worldwide trends in mortality related to Parkinson's disease in the period of 1994\u20132019: analysis of vital registration data from the WHO mortality database","volume":"13","author":"Lampropoulos","year":"2022","journal-title":"Front Neurol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.parkreldis.2015.12.008","article-title":"Environmental risk factors and Parkinson's disease: an umbrella review of meta-analyses","volume":"23","author":"Bellou","year":"2016","journal-title":"Parkinsonism Relat Disord"},{"key":"B5","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/s41531-023-00462-8","article-title":"A nationwide cohort study on diabetes severity and risk of Parkinson disease","volume":"9","author":"Han","year":"2023","journal-title":"NPJ Parkinsons Dis"},{"key":"B6","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1001\/jamaneurol.2019.3446","article-title":"Risk of developing Parkinson disease in bipolar disorder: a systematic review and meta-analysis","volume":"77","author":"Faustino","year":"2020","journal-title":"JAMA Neurol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"18008","DOI":"10.1038\/nrdp.2018.8","article-title":"Bipolar disorders","volume":"4","author":"Vieta","year":"2018","journal-title":"Nat Rev Dis Primers"},{"key":"B8","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1007\/s100720200073","article-title":"Association between bipolar disorder and Parkinson's disease","volume":"35","author":"Geelhand de Merxem","year":"2023","journal-title":"Psychiatr Danub"},{"key":"B9","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s12929-021-00742-6","article-title":"Inflammatory signaling mechanisms in bipolar disorder","volume":"28","author":"Jones","year":"2021","journal-title":"J Biomed Sci"},{"key":"B10","doi-asserted-by":"publisher","first-page":"75","DOI":"10.5080\/u18376","article-title":"Erken Evre ve Kronik Bipolar Bozukluk Hastalarinda Inflamasyon ve N\u00f6rodejenerasyon Bulgulari. tur. [Inflammation and neurodegeneration in patients with early-stageand chronic bipolar disorder]","volume":"30","author":"Karabulut","year":"2019","journal-title":"Turk Psikiyatri Derg"},{"key":"B11","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1111\/j.1600-0447.2007.01058.x","article-title":"Dopamine dysregulation syndrome: implications for a dopamine hypothesis of bipolar disorder","volume":"116","author":"Berk","year":"2007","journal-title":"Acta Psychiatr Scand Suppl"},{"key":"B12","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.psc.2015.09.006","article-title":"Bipolar disorder and inflammation","volume":"39","author":"Rosenblat","year":"2016","journal-title":"Psychiatr Clin North Am"},{"key":"B13","doi-asserted-by":"publisher","first-page":"360481","DOI":"10.1155\/2014\/360481","article-title":"Cytokines in bipolar disorder: paving the way for neuroprogression","volume":"2014","author":"Barbosa","year":"2014","journal-title":"Neural Plast"},{"key":"B14","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.brainres.2008.03.081","article-title":"Cytokines disrupt intracellular patterns of Parkinson's disease-associated proteins alpha-synuclein, tau and ubiquitin in cultured glial cells","volume":"1217","author":"Bick","year":"2008","journal-title":"Brain Res"},{"key":"B15","doi-asserted-by":"publisher","first-page":"n160","DOI":"10.1136\/bmj.n160","article-title":"PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"B16","doi-asserted-by":"publisher","first-page":"b2700","DOI":"10.1136\/bmj.b2700","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration","volume":"339","author":"Liberati","year":"2009","journal-title":"BMJ"},{"key":"B17","doi-asserted-by":"publisher","first-page":"i4919","DOI":"10.1136\/bmj.i4919","article-title":"ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions","volume":"355","author":"Sterne","year":"2016","journal-title":"BMJ"},{"key":"B18","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1007\/s10654-010-9491-z","article-title":"Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses","volume":"25","author":"Stang","year":"2010","journal-title":"Eur J Epidemiol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"GRADE: an emerging consensus on rating quality of evidence and strength of recommendations","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"key":"B20","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"B21","doi-asserted-by":"publisher","first-page":"E901","DOI":"10.1503\/cmaj.200077","article-title":"Development of the instrument to assess the credibility of effect modification analyses (ICEMAN) in randomized controlled trials and meta-analyses","volume":"192","author":"Schandelmaier","year":"2020","journal-title":"CMAJ"},{"key":"B22","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1111\/j.1600-0447.2001.00372.x","article-title":"Increased risk of developing Parkinson's disease for patients with major affective disorder: a register study","volume":"104","author":"Nilsson","year":"2001","journal-title":"Acta Psychiatr Scand"},{"key":"B23","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.annepidem.2013.12.010","article-title":"Psychiatric diseases predated the occurrence of Parkinson disease: a retrospective cohort study","volume":"24","author":"Lin","year":"2014","journal-title":"Ann Epidemiol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.jagp.2015.11.004","article-title":"Lithium use in older adults is associated with increased prescribing of Parkinson medications","volume":"24","author":"Marras","year":"2016","journal-title":"Am J Geriatr Psychiatry"},{"key":"B25","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1111\/pcn.13759","article-title":"Risk of subsequent Parkinson's disease among patients with bipolar disorder or major depression: a nationwide longitudinal study in Taiwan","volume":"79","author":"Huang","year":"2025","journal-title":"Psychiatry Clin Neurosci"},{"key":"B26","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1038\/s41531-024-00794-z","article-title":"Prospective study of bipolar disorder and neurodegenerative diseases","volume":"10","author":"Xu","year":"2024","journal-title":"NPJ Parkinsons Dis"},{"key":"B27","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1038\/s41531-023-00621-x","article-title":"Different risks of early-onset and late-onset Parkinson disease in individuals with mental illness","volume":"10","author":"Yoon","year":"2024","journal-title":"NPJ Parkinsons Dis"},{"key":"B28","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1002\/ajmg.b.30032","article-title":"COMT: a common susceptibility gene in bipolar disorder and schizophrenia","author":"Shifman","year":"2004","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"B29","doi-asserted-by":"publisher","first-page":"3132","DOI":"10.1093\/hmg\/ddl253","article-title":"Hypomethylation of MB-COMT promoter is a major risk factor for schizophrenia and bipolar disorder","volume":"15","author":"Abdolmaleky","year":"2006","journal-title":"Hum Mol Genet"},{"key":"B30","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.jad.2014.01.015","article-title":"The DRD2 rs1800497 polymorphism increase the risk of mood disorder: evidence from an update meta-analysis","volume":"158","author":"Zhang","year":"2014","journal-title":"J Affect Disord"},{"key":"B31","doi-asserted-by":"publisher","first-page":"e17136","DOI":"10.1097\/MD.0000000000017136","article-title":"Association between the DRD2 TaqIA gene polymorphism and Parkinson disease risk: an updated meta-analysis","volume":"98","author":"Yu","year":"2019","journal-title":"Medicine (Baltimore)"},{"key":"B32","doi-asserted-by":"publisher","first-page":"275","DOI":"10.3892\/br.2014.220","article-title":"Polymorphisms of DRD2 and DRD3 genes and Parkinson's disease: a meta-analysis","volume":"2","author":"Dai","year":"2014","journal-title":"Biomed Rep"},{"key":"B33","doi-asserted-by":"publisher","first-page":"3649","DOI":"10.1007\/s10072-021-05829-4","article-title":"Polymorphisms of the dopamine metabolic and signaling pathways are associated with susceptibility to motor levodopa-induced complications (MLIC) in Parkinson's disease: a systematic review and meta-analysis","volume":"43","author":"Soraya","year":"2022","journal-title":"Neurol Sci"},{"key":"B34","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1002\/ana.21716","article-title":"Dopamine D2 receptor knockout mice develop features of Parkinson disease","volume":"66","author":"Tinsley","year":"2009","journal-title":"Ann Neurol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.biopsych.2013.01.007","article-title":"Cytokine alterations in bipolar disorder: a meta-analysis of 30 studies","volume":"74","author":"Modabbernia","year":"2013","journal-title":"Biol Psychiatry"},{"key":"B36","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1016\/j.bbi.2009.04.008","article-title":"Abnormalities in serum chemokine levels in euthymic patients with bipolar disorder","volume":"23","author":"Brietzke","year":"2009","journal-title":"Brain Behav Immun"},{"key":"B37","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.jad.2008.12.001","article-title":"Comparison of cytokine levels in depressed, manic and euthymic patients with bipolar disorder","volume":"116","author":"Brietzke","year":"2009","journal-title":"J Affect Disord"},{"key":"B38","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/S0006-3223(02)01452-X","article-title":"High numbers of circulating activated T cells and raised levels of serum IL-2 receptor in bipolar disorder","volume":"53","author":"Breunis","year":"2003","journal-title":"Biol Psychiatry"},{"key":"B39","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1515\/hsz-2015-0257","article-title":"Kinins and microglial responses in bipolar disorder: a neuroinflammation hypothesis","volume":"397","author":"Naaldijk","year":"2016","journal-title":"Biol Chem"},{"key":"B40","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1503\/jpn.140183","article-title":"Monocyte and microglial activation in patients with mood-stabilized bipolar disorder","volume":"40","author":"Jakobsson","year":"2015","journal-title":"J Psychiatry Neurosci"},{"key":"B41","doi-asserted-by":"publisher","first-page":"999","DOI":"10.2174\/1381612053381620","article-title":"Inflammatory process in Parkinson's disease: role for cytokines","volume":"11","author":"Nagatsu","year":"2005","journal-title":"Curr Pharm Des"},{"key":"B42","doi-asserted-by":"publisher","first-page":"383","DOI":"10.3390\/biom15030383","article-title":"The association among bipolar disorder, mitochondrial dysfunction, and reactive oxygen species","volume":"15","author":"Kageyama","year":"2025","journal-title":"Biomolecules"},{"key":"B43","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.1212\/WNL.0b013e31826e25ce","article-title":"Past exposure to neuroleptic drugs and risk of Parkinson disease in an elderly cohort","volume":"79","author":"Foubert-Samier","year":"2012","journal-title":"Neurology"},{"key":"B44","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1111\/bdi.13300","article-title":"Lithium and risk of cardiovascular disease, dementia and venous thromboembolism","volume":"25","author":"Ponzer","year":"2023","journal-title":"Bipolar Disord"},{"key":"B45","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1038\/mp.2016.96","article-title":"Lithium suppression of tau induces brain iron accumulation and neurodegeneration","volume":"22","author":"Lei","year":"2017","journal-title":"Mol Psychiatry"},{"key":"B46","doi-asserted-by":"publisher","first-page":"271","DOI":"10.2169\/internalmedicine.51.6483","article-title":"Differential association between HLA and diffuse panbronchiolitis in Northern and Southern Chinese","volume":"51","author":"Chen","year":"2012","journal-title":"Intern Med"},{"key":"B47","first-page":"467","article-title":"Ethnicity and psychotropic drugs","volume":"10","author":"Bond","year":"1991","journal-title":"Clin Pharm"},{"key":"B48","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1111\/j.1440-1681.2007.04616.x","article-title":"Oestrogen and nigrostriatal dopaminergic neurodegeneration: animal models and clinical reports of Parkinson's disease","volume":"34","author":"Liu","year":"2007","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"B49","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.steroids.2007.02.003","article-title":"Neurotrophic and neuroprotective actions of estrogen: basic mechanisms and clinical implications","volume":"72","author":"Brann","year":"2007","journal-title":"Steroids"},{"key":"B50","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1385\/ENDO:21:1:77","article-title":"Estrogens and Parkinson disease: novel approach for neuroprotection","volume":"21","author":"Sawada","year":"2003","journal-title":"Endocrine"},{"key":"B51","doi-asserted-by":"publisher","first-page":"984829","DOI":"10.3389\/fpsyt.2022.984829","article-title":"Prevalence and associated factors of obesity and overweight in Chinese patients with bipolar disorder","volume":"13","author":"Yi","year":"2022","journal-title":"Front Psychiatry"},{"key":"B52","doi-asserted-by":"publisher","first-page":"203930","DOI":"10.1155\/2014\/203930","article-title":"Meta-analysis: overweight, obesity, and Parkinson's disease","volume":"2014","author":"Chen","year":"2014","journal-title":"Int J Endocrinol"},{"key":"B53","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1089\/cap.2009.0036","article-title":"Psychotropic medication exposure and age at onset of bipolar disorder in offspring of parents with bipolar disorder","volume":"20","author":"Chang","year":"2010","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"B54","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1007\/s13760-023-02424-6","article-title":"The risk of Parkinson's disease in diabetic people: an updated systematic review and meta-analysis","volume":"124","author":"Azami","year":"2024","journal-title":"Acta Neurol Belg"},{"key":"B55","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1289\/ehp.1002839","article-title":"Rotenone, paraquat, and Parkinson's disease","volume":"119","author":"Tanner","year":"2011","journal-title":"Environ Health Perspect"},{"key":"B56","doi-asserted-by":"publisher","first-page":"1996","DOI":"10.1093\/brain\/awae073","article-title":"Genetic analysis and natural history of Parkinson's disease due to the LRRK2 G2019S variant","volume":"147","author":"Kmiecik","year":"2024","journal-title":"Brain"}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2026.1825046\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T04:59:14Z","timestamp":1780635554000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2026.1825046\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,5]]},"references-count":56,"alternative-id":["10.3389\/fneur.2026.1825046"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2026.1825046","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,5]]},"article-number":"1825046"}}